RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. The Fink Family Office
T

The Fink Family Office portfolio

The Fink Family Office has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $5.07M.
Latest deal: MitoRx Therapeutics · Dec 18, 2023.
About this page

Its most recent investment on record is MitoRx Therapeutics's $5.07M Seed round in December 2023, alongside UK Innovation & Science Seed Fund, Oxford Technology Management, Longevitytech.fund and 2 others. That company is in Health and bio. It has co-invested with Oxford Technology Management, UK Innovation & Science Seed Fund and Longevitytech.fund, most often Oxford Technology Management (2 rounds).

What The Fink Family Office invests in

How The Fink Family Office invests

StageDealsCapital in rounds
Seed 2 100%$5.07M
YearDealsCapital in rounds
2022 1 50%undisclosed
2023 1 50%$5.07M

The Fink Family Office portfolio companies

CompanyRound with The Fink Family OfficeTotal raisedLatest raise
MMitoRx Therapeutics
Health and bio
Seed · $5.07M$5.07MNov 17, 2025
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name The Fink Family Office. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists The Fink Family Office, which is a subset of its real portfolio. API: /api/v1/investors/the-fink-family-office (get a free API key). More: the most active VC firms and new venture capital funds.